The Association of Docetaxel Side Effects and Introduction of Subsequent Cabazitaxel for Castration-Resistant Prostate Cancer : A Clinical Study
The administration of cabazitaxel for patients with castration-resistant prostate cancer (CRPC) requires prior docetaxel therapy. Sequential chemotherapy may have to be discontinued due to docetaxelassociated side effects. This study investigated the relationship between treatment outcome of docetax...
Ausführliche Beschreibung
Bibliographische Detailangaben
| Veröffentlicht in: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 70(2024), 6 vom: 05. Juni, Seite 141-147
|
|---|
| 1. Verfasser: |
Kujime, Yuma
(VerfasserIn) |
|---|
| Weitere Verfasser: |
Sato, Mototaka,
Maekawa, Takahiro,
Umeda, Shun,
Matsushita, Makoto,
Tei, Norihide,
Miyake, Osamu |
|---|
| Format: | Online-Aufsatz
|
|---|
| Sprache: | Japanese |
|---|
| Veröffentlicht: |
2024
|
|---|
| Zugriff auf das übergeordnete Werk: | Hinyokika kiyo. Acta urologica Japonica
|
|---|
| Schlagworte: | English Abstract
Journal Article
cabazitaxel
51F690397J
Taxoids
Docetaxel
15H5577CQD
Antineoplastic Agents |
|---|